Latest Dilution News

Challenger Gold has poured its first gold bar from the Hualilán project in Argentina, initiating a production ramp-up under a toll milling agreement that secures processing capacity for three years.

ANZ Group Holdings Limited has updated details for its 2026 Interim Dividend, confirming an 83-cent payment per share, partially franked, with dividend reinvestment and bonus option plans priced at AUD 35.31.

AoFrio Limited has initiated a 1-for-7 renounceable rights offer at NZ$0.07 per share aiming to raise nearly NZ$5 million. This follows a recent $4.56 million placement and supports an aggressive growth strategy targeting $300 million revenue by 2030.

Strata Minerals has secured a binding agreement with BML Ventures to fund and manage mining at its Zelica Gold Project, paving a capital-light path to production and profit sharing.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

Barton Gold has raised $25.5 million through an institutional placement, fully funding critical feasibility studies and resource upgrades across its Challenger, Tunkillia, and Tolmer projects in South Australia.

Canadian Phosphate (ASX: CP8) is raising up to AUD 4.85 million via a renounceable rights issue at a 22% discount, aiming to accelerate development of its newly acquired Diamond Mountain Project in Utah and advance exploration in Canada.

Evion Group has increased the size of its second tranche placement, lifting total capital raised to A$7.24 million through the issue of over 241 million shares at 3 cents each. The second tranche awaits shareholder approval at a July meeting, including director participation and free attaching options.

Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.

Elanor Investors Group has called off its planned acquisition of Singapore-based Firmus Capital due to prolonged regulatory delays, while reaffirming its $125 million recapitalisation with Rockworth Capital Partners and seeking ASX trading reinstatement.

Arafura Rare Earths has successfully completed the first tranche of its A$350 million placement, issuing 675.1 million shares and raising approximately A$175.5 million before costs. The second tranche awaits shareholder approval.